Bandebereho Father Groups Randomized Control Trial in Rwanda

NCT02694627 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2400

Last updated 2017-04-04

No results posted yet for this study

Summary

This study seeks to assess the impact of the MenCare+/Bandebereho fathers'/couples' group education intervention on men's attitudes towards, and participation in, sexual and reproductive health, maternal, newborn and child health, and equitable and non-violent relationships with their children and partners.

Conditions

  • Gender Relations
  • Prenatal Care
  • Partner Communication
  • Contraception
  • Violence

Interventions

BEHAVIORAL

MenCare+/Bandebereho fathers'/couples' group education

MenCare+/Bandebereho is a 3 year project to engage men in maternal, newborn and child health (MNCH) and in sexual and reproductive health in Rwanda. A core component of the project is fathers'/couples' group education. The target participants are first-time parents or parents of young children living in 16 rural and semi-urban sectors selected by the implementing partner in collaboration with local authorities. The MenCare+/Bandebereho fathers'/couples' group education engages men in 15 weekly sessions of group discussion, critical reflection and interactive activities led by a trained facilitator using a curriculum developed by RWAMREC and Promundo and approved by the Rwandan Ministry of Health, adapted from the Program P Manual. Men's partners participate in 6-8 sessions. The sessions focus on men's role in MNCH, family planning, sharing household responsibilities, intimate partner violence, conflict resolution, family budgeting, and gender equality.

Sponsors & Collaborators

  • Rwanda Men's Resource Center (Rwamrec)

    collaborator UNKNOWN
  • Promundo, United States

    lead OTHER

Principal Investigators

  • Kate E Doyle, MA · Promundo-US

  • Ruti G Levtov, PhD · Promundo-US

  • Gary Barker, PhD · Promundo-US

  • Shamsi Kazimbaya, MA · formerly at Rwanda Men's Resource Center, now at Jhpiego

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2017-01-31
Completion
2017-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02694627 on ClinicalTrials.gov